CompletedNCT04046497
AI Smartphone Support for Taking Medication in Early Psychosis
About this title
Read the official source — NCT04046497Interventional studyAges 15–40United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 15 years to 40 years.
- Listed locations
- Hialeah and 4 more locationsSee all locations and recruitment
Study information
Study start dateStarted: November 20, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 139
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 15 Years to 40 Years
- Official registry ID
- NCT04046497
- Official title
Show the full official title
Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hialeah · Grand Rapids · Kalamazoo
2 more locations
- Oklahoma City
- Tulsa
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Who was this study for?
Listed age limits: 15 years to 40 years.
